Full Text View
Tabular View
No Study Results Posted
Related Studies
Botulinum Toxin (BOTOX) for Cerebral Palsy
This study is ongoing, but not recruiting participants.
Study NCT00060957   Information provided by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
First Received: May 16, 2003   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cerebral Palsy
Muscle Spasticity
Additional conditions recognized in this trial
Paralysis
More general conditions related to this trial
Brain Damage, Chronic
Brain Diseases
Central Nervous System Diseases
Muscle Hypertonia
Muscular Diseases
Musculoskeletal Diseases
Nervous System Diseases
Neurologic Manifestations
Neuromuscular Manifestations
Signs and Symptoms
Interventions listed in this trial
Botulinum toxin type A
Additional drug interventions recognized in this trial
Botulinum Toxins
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Central Nervous System Agents
Neuromuscular Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services